RENEE WALTER: Open Payments
NPI 1245948041 · MYRTLE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,609 in 89 payments from 15 companies in 2025. Trend: 2023 $311 · 2024 $277 · 2025 $1,609
Food & beverage: $1,609
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $425 |
| Otsuka America Pharmaceutical, Inc. | 11 | $295 |
| Supernus Pharmaceuticals, Inc. | 8 | $222 |
| Alkermes, Inc. | 7 | $148 |
| Neurocrine BioSciences, Inc. | 6 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 1 | $31 |
Products named: VRAYLAR, REXULTI, Qelbree, INGREZZA, ARISTADA, TRINTELLIX, Auvelity, Jornay PM.
Industry payments across SC — which companies pay providers there.
